Summary | Novel Fusion Proteins for HIV Vaccine

This is the pilot version of Therapoid. Register or Sign in as a pilot user to collaborate.

Provided by: National Institutes of Health (NIH)
Tags: anti-cancer cancer Breast Cancer GPCR Cell Line

Short Description:

This technology pertains to gp120 and CD4-induced antibody fusion proteins for use in an HIV vaccine.